Search
Now showing items 1-7 of 7
The True Colours Remote Symptom Monitoring System: A Decade of Evolution
(2020-01)
The True Colours remote mood monitoring system was developed over a decade ago by researchers, psychiatrists, and software engineers at the University of Oxford to allow patients to report on a range of symptoms via text ...
Adjunctive Psychotherapy for Bipolar Disorder A Systematic Review and Component Network Meta-analysis
(2020-10)
Importance Several psychotherapy protocols have been evaluated as adjuncts to pharmacotherapy for patients with bipolar disorder, but little is known about their comparative effectiveness.
Objective To use systematic ...
Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS
(2020-01)
Aims and method True Colours is an automated symptom monitoring programme
used by National Health Service psychiatric services. This study explored whether
patients with unipolar treatment-resistant depression (TRD) found ...
Introducing artificial intelligence in acute psychiatric inpatient care: qualitative study of its use to conduct nursing observations.
(2020-02)
Background All patients admitted to an acute inpatient mental health unit must have nursing observations carried out at night either hourly or every 15 minutes, to ascertain that they are safe and breathing. However, while ...
How pharmacist prescribers can help meet the mental health consequences of COVID-19
(2020-11)
We suggest that Mental Health Trusts
should urgently develop prescribing roles
for specialist mental health pharmacists,
which are integrated within mental health
teams. In these roles, prescribing pharmacists can ...
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
(2020)
Background
Adverse mental health consequences of COVID-19, including anxiety and depression, have been widely predicted but not yet accurately measured. There are a range of physical health risk factors for COVID-19, but ...
Melatonin In Acute Mania Investigation (MIAMI‐UK). A randomised controlled trial of add‐on melatonin in bipolar disorder
(2020-05)
Objectives
Current options for treating emergent episodes of hypomania and mania in bipolar disorder are limited. Our objective was to compare the effectiveness and safety of add‐on melatonin in hypomania or mania over ...